| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/17/2010 | US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics |
| 08/17/2010 | US7776311 D-amino acid peptides |
| 08/17/2010 | CA2547591C Novel compounds and compositions as cathepsin inhibitors |
| 08/17/2010 | CA2427227C Lactam compound |
| 08/12/2010 | WO2010074542A9 NANOSTRUCTURES HAVING STABILIZED MULTIPLE α-HELICAL STRUCTURES, SELF-ASSEMBLING MACROCYCLIC COMPOUNDS FOR FORMING THE NANOSTRUCTURES, AND METHODS OF PREPARING THE COMPOUND |
| 08/12/2010 | WO2010054102A3 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 08/12/2010 | US20100204448 Method and carrier complexes for delivering molecules to cells |
| 08/12/2010 | US20100204159 Organic compounds and their uses |
| 08/12/2010 | US20100204088 Cyclic Peptide Antitumor Agents |
| 08/12/2010 | US20100203066 Polymeric linkers containing pyridyl disulfide moieties |
| 08/12/2010 | US20100202961 Immunological reagents for therapeutic use, in radioimmunotherapy (RAIT), and diagnostic use, in radioimmunodetection (RAID) and magnetic resonance imaging; conjugated drug as antiinflammatory, or anticarcinogenic agents; drug targets; tissue-targeted therapy |
| 08/11/2010 | CN1712399B Production and use for taxol and muramic acyl dipeptide conjugate substance of immune reinforcer |
| 08/11/2010 | CN1680427B Water soluble piduomode composite salt and its preparation |
| 08/11/2010 | CN101801994A Preparation of Romidepsin |
| 08/11/2010 | CN101161674B Cyclopeptide, preparation method and uses thereof |
| 08/10/2010 | US7772427 Uses for amino acid anticonvulsants |
| 08/10/2010 | US7772413 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents |
| 08/10/2010 | US7772397 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles |
| 08/10/2010 | US7772367 polypeptides that induce apoptosis of cancer cells that contain mutant p53 or over-expressed wild-type p53 |
| 08/10/2010 | US7772366 inflammation, autoimmune diseases, neurodegenerative diseases; a)hydrogen bonding moieties binding with a different backbone atom of ICE; b)hydrophobic moieties c)electronegative moiety; t-Butyl N-[(N-acetyl-O-t-butyltyrosinyl)-valaninyl-alaninyl]-3-amino-5-(2,6-dich- lorophenylmethyloxy)-4-oxo-pentanoat |
| 08/10/2010 | US7772363 Two helix binders |
| 08/10/2010 | US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds |
| 08/10/2010 | US7772177 pyrrolidine compounds; cellular apoptosis through inhibition of apoptosis proteins (IAP) modulation to treat proliferative disorders such as cancer; bioavailability; 2-aminomethyl-substituted; aminomethylcarbonylaminomethylcarbonyl-substitution on ring Nitrogen; three baculovirus IAP repeat (BIR) domains |
| 08/10/2010 | US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 08/10/2010 | CA2451768C Peptoid compounds |
| 08/10/2010 | CA2451605C Diamine derivatives |
| 08/10/2010 | CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 08/05/2010 | WO2010086101A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof |
| 08/05/2010 | US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 08/05/2010 | US20100197607 Mucin hypersecretion inhibitors and methods of use |
| 08/05/2010 | US20100197576 Polypeptides or fusion proteins thereof inhibiting transmigration of leucocytes or growth and/or metastasis of cancer cells |
| 08/05/2010 | US20100196458 Modified cytokines for use in cancer therapy |
| 08/05/2010 | US20100196271 Cage-Like Bifunctional Chelators, Copper-64 Radiopharmaceuticals and PET Imaging Using the Same |
| 08/05/2010 | US20100196270 Radiofluorination methods |
| 08/05/2010 | CA2750769A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof |
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit |
| 08/04/2010 | EP2213295A1 A method for obtaining data useful in the identification of a patient at risk of having difficulty in sustaining a pregnancy |
| 08/04/2010 | EP2212343A2 Peptide gap junction modulators |
| 08/04/2010 | EP2212334A1 Proteasome inhibitors |
| 08/04/2010 | CN101796066A Biomolecule binding ligands |
| 08/04/2010 | CN101796064A Method for producing peptide |
| 08/04/2010 | CN101792483A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus |
| 08/04/2010 | CN101791394A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 08/03/2010 | US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes |
| 08/03/2010 | US7767649 Gamma aminobutyric acid antagonist; naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative disorders; analgesics; drug withdrawal |
| 08/03/2010 | US7767648 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs |
| 08/03/2010 | US7767645 2-{(9S,10S,14R,18S)-7,16,19-Triaza-18-(carbamoylmethyl)-14-[(5-methyl indolyl)methyl]-8,17,20-trioxo-10-[4-(phosphonomethyl)phenyl]spiro[5.14]icos-11-en-9-yl}acetic acid; anticarcinogen |
| 08/03/2010 | US7767200 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 08/03/2010 | CA2265853C Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ice)/ced-3 family inhibitors |
| 07/29/2010 | WO2010058419A4 Tumor necrosis factor alpha inhibiting peptides and uses thereof |
| 07/29/2010 | WO2009115658A9 Use of a caspase-1 inhibitor for treating atherosclerotic plaque |
| 07/29/2010 | US20100190725 Amino acid derivatives |
| 07/29/2010 | US20100190724 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 07/29/2010 | US20100190723 Preventive or therapeutic composition for liver disease |
| 07/29/2010 | US20100190718 Methods for preventing or treating mitochondrial permeability transition |
| 07/29/2010 | US20100190710 Il-23 receptor antagonists and uses thereof |
| 07/29/2010 | US20100190183 Protein labelling with tags comprising isotope-coded sub-tags and isobaric sub-tags |
| 07/29/2010 | US20100189658 Imaging probes |
| 07/28/2010 | EP2211176A2 Analyzing nerve cell damage |
| 07/28/2010 | EP2210612A2 Macrocyclic antagonists of the motilin receptor |
| 07/28/2010 | EP2210598A2 Anticonvulsant amino acids for the treatment of pain |
| 07/28/2010 | EP2209374A1 Tubulysins and processes for preparing |
| 07/28/2010 | EP1397486B1 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN101790536A Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 07/27/2010 | US7763710 ALS-specific peptide composition |
| 07/27/2010 | US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/27/2010 | US7763281 hypotensive polypeptide in dairy product food; milk proteins as inhibitor of angiotensin I-converting enzyme; treating cardiovascular disease |
| 07/27/2010 | CA2548405C Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 07/27/2010 | CA2462686C Fret protease assays for clostridial toxins |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/22/2010 | WO2010082367A1 Angiotensin converting enzyme-inhibiting peptide |
| 07/22/2010 | WO2010082177A2 New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
| 07/22/2010 | WO2010082176A2 Cosmetic composition containing kxk type peptides and uses |
| 07/22/2010 | WO2010082175A2 New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
| 07/22/2010 | WO2003099841A9 Peptides and the use thereof in darkening the skin |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184706 Fap-activated chemotherapeutic compounds, and methods of use thereof |
| 07/22/2010 | US20100184663 Methods and Compositions Related to Inhibition of Viral Entry |
| 07/22/2010 | US20100184628 Bis-sulfhydryl macrocyclization systems |
| 07/22/2010 | US20100184597 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants |
| 07/22/2010 | US20100184106 Thrombin Substrate and Assay for Determining the Level of Bioactive Thrombin in a Sample |
| 07/22/2010 | US20100183551 Macrocyclic Compounds As Antiviral Agents |
| 07/21/2010 | EP2207791A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/21/2010 | EP2207790A1 Biologically active c-terminal arginine-containing peptides |
| 07/21/2010 | EP2207768A1 Improved ramipril synthesis |
| 07/21/2010 | CN101781356A Arginine hybrid cell-penetrating peptide and application thereof |
| 07/20/2010 | US7759519 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents |
| 07/20/2010 | US7759514 peptidomimetics such as (Z)-8-Amino-2-benzyl-3,7-dihydroxy-9-(4-hydroxy-phenyl)-non-4-enoic acid (1-carbamoyl-2-phenyl-ethyl)-amide, having improved selectivity to targets, improved bioavailability and lessened adverse side effects, used as analgesics |
| 07/20/2010 | US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases |
| 07/20/2010 | US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies |
| 07/20/2010 | CA2366694C Process for the preparation of cyclo (asp-dphe-nmeval-arg-gly) |
| 07/15/2010 | WO2010080389A1 Hcv ns3 protease inhibitors |
| 07/15/2010 | WO2010079286A1 Novel anti-ageing peptides, and cosmetic and/or pharmaceutical composition containing same |
| 07/15/2010 | WO2010079285A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same |
| 07/15/2010 | WO2010079284A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same |
| 07/15/2010 | WO2010048941A3 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic |
| 07/15/2010 | US20100178710 Mass Labels |
| 07/15/2010 | US20100178242 Labelling methods |
| 07/15/2010 | CA2747636A1 Hcv ns3 protease inhibitors |